Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9 th -12 th , connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below along with webcasting links to view pre...
HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the publication of preclinical data from its GoCAR-NK™ Cell Program in the digital edition of Blood...
HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual investor conferences. Conference Details: ...
Gainers: Protagonist Therapeutics (NASDAQ: PTGX ) +74% . More news on: Protagonist Therapeutics, Inc., Everspin Technologies, Inc., American Axle & Manufacturing Holdings, Inc., Stocks on the move, , Read more ...
Bellicum Pharmaceuticals (NASDAQ: BLCM ): Q1 EPS of $1.09 may not be comparable to consensus of -$2.73. More news on: Bellicum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Bellicum’s three GoCAR™ programs remain on track Completed $15 million sale of manufacturing, office and laboratory facility to MD Anderson and entered into supply agreement HOUSTON, May 07, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a le...
Purchase price of $15 million from sale of manufacturing, office and laboratory facility Current and future GoCAR™ product candidates to be manufactured by MD Anderson HOUSTON, April 15, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in deve...
Gainers: Champions Oncology (NASDAQ: CSBR ) +38% . More news on: Champions Oncology, Inc., PFSweb, Inc., Mayville Engineering Company, Inc., Stocks on the move, , Read more ...
Bellicum Pharmaceuticals, Inc. (BLCM) Q4 2019 Earnings Conference Call March 12, 2020, 05:00 PM ET Company Participants Stephen Jasper - Westwicke, IR Richard Fair - President, CEO Atabak Mokari - CFO Aaron Foster - Head of Research & Senior VP Conference Call Participan...
Bellicum Pharmaceuticals (NASDAQ: BLCM ): Q4 GAAP EPS of -$5.82 misses by $1.49 . Revenue of $5.13M vs. $0.31M in 4Q18. Press Release More news on: Bellicum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Bellicum Pharmaceuticals Inc. Company Name:
BLCM Stock Symbol:
NASDAQ Market:
Bellicum Pharmaceuticals Inc. Website:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...